[go: up one dir, main page]

AU2009902280A0 - Improved therapeutic formulations - Google Patents

Improved therapeutic formulations

Info

Publication number
AU2009902280A0
AU2009902280A0 AU2009902280A AU2009902280A AU2009902280A0 AU 2009902280 A0 AU2009902280 A0 AU 2009902280A0 AU 2009902280 A AU2009902280 A AU 2009902280A AU 2009902280 A AU2009902280 A AU 2009902280A AU 2009902280 A0 AU2009902280 A0 AU 2009902280A0
Authority
AU
Australia
Prior art keywords
improved therapeutic
therapeutic formulations
formulations
improved
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009902280A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OzPharma Pty Ltd
Original Assignee
OzPharma Pty Ltd
Filing date
Publication date
Application filed by OzPharma Pty Ltd filed Critical OzPharma Pty Ltd
Publication of AU2009902280A0 publication Critical patent/AU2009902280A0/en
Priority to US13/256,844 priority Critical patent/US20120058962A1/en
Priority to BRPI1012170A priority patent/BRPI1012170A2/en
Priority to JP2012511094A priority patent/JP2012527406A/en
Priority to AU2010262738A priority patent/AU2010262738A1/en
Priority to PCT/AU2010/000594 priority patent/WO2010144943A1/en
Priority to CA2761538A priority patent/CA2761538A1/en
Priority to MX2011012078A priority patent/MX2011012078A/en
Priority to CN2011800021286A priority patent/CN102612363A/en
Priority to EP10788488.4A priority patent/EP2437730A4/en
Priority to AU2016238901A priority patent/AU2016238901A1/en
Priority to AU2018217251A priority patent/AU2018217251A1/en
Abandoned legal-status Critical Current

Links

AU2009902280A 2009-05-20 2009-05-20 Improved therapeutic formulations Abandoned AU2009902280A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
EP10788488.4A EP2437730A4 (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation
PCT/AU2010/000594 WO2010144943A1 (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation
BRPI1012170A BRPI1012170A2 (en) 2009-05-20 2010-05-20 formulation and / or sublingual and method for reducing the amount of active compound used to achieve an effect on a patient compared to a typical compound that is ingested.
JP2012511094A JP2012527406A (en) 2009-05-20 2010-05-20 Oral and / or sublingual preparations
AU2010262738A AU2010262738A1 (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation
US13/256,844 US20120058962A1 (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation
CA2761538A CA2761538A1 (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation
MX2011012078A MX2011012078A (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation.
CN2011800021286A CN102612363A (en) 2009-05-20 2010-05-20 Buccal and/or sublingual therapeutic formulation
AU2016238901A AU2016238901A1 (en) 2009-05-20 2016-10-06 Buccal and/or sublingual therapeutic formulation
AU2018217251A AU2018217251A1 (en) 2009-05-20 2018-08-15 Buccal and/or sublingual therapeutic formulation

Publications (1)

Publication Number Publication Date
AU2009902280A0 true AU2009902280A0 (en) 2009-06-04

Family

ID=

Similar Documents

Publication Publication Date Title
EP2493478B8 (en) Concentrated therapeutic phospholipid compositions
ZA201106050B (en) Dye-polymers formulations
SI3061445T1 (en) Highly concentrated pharmaceutical formulations
GB0815435D0 (en) Formulations
EP2359741A4 (en) Endoscope
GB0807905D0 (en) Formulations
IL269369A (en) Improved formulations
GB0919210D0 (en) Formulations
EP2307021A4 (en) Formulations
WO2010114629A9 (en) Formulation
GB0900786D0 (en) Therapeutic compositions
IL217390A0 (en) Formulations
WO2011072138A9 (en) Therapeutic use of protein-polymer conjugates
AU2009902280A0 (en) Improved therapeutic formulations
GB0816878D0 (en) Formulations
AU2009905633A0 (en) Formulations
AU2009905978A0 (en) Inhalable formulations
AU2014201356B2 (en) Combined measles-malaria vaccine
AU2009902960A0 (en) Therapeutic Protocol
AU2008906012A0 (en) Therapeutic compositions
AU2009905152A0 (en) Combination therapy
AU2009904098A0 (en) Combination Therapy
HK1168531A (en) Vesicular formulations
AU2009100840A4 (en) Proctective Skin
GB0917744D0 (en) Formulations